| | August 20202UTLOOKHealthcare Tech The COVID-19 pandemic has accelerated the need for and use of telehealth solutions, to keep vulnerable patients safe and out of clinic.Now is a unique time in the evolution of healthcare. It represents a real paradigm shift in how healthcare will be delivered across the globe, now and going forward.At Glooko, we are leaning into this change by driving innovation, increased access, and improved health outcomes for people with diabetes, through our market-leading telehealth and remote care solutions.THE GLOOKO PLATFORMOur software platforms, Glooko® and diasend®, empower diabetes management by collecting and unlocking the power of data from blood-glucose meters, CGMs, insulin pumps, pens and activity trackers ­ bringing insights together in one place. Data is easily uploaded - remotely via app or in-clinic, securely shared and visualized in actionable charts and graphs. This creates a solid foundation enabling collaboration and confident treatment decisions. The platforms are compatible with the vast majority of diabetes devices available, giving people with diabetes and their care teams the freedom of choice.2.8 million users have benefited from diabetes data insights using our solutions, which are trusted by world leaders in diabetes care, and used in 26 countries across 15 languages. Learn more at glooko.com. © 2020 Glooko IncMKT-0221 01Transforming digital health22B+ data points of real world data4,700 active monthly clinics300,000 active montly patients Clinical locations across 26 countriesConnect with us at glooko.com for improved decision making and clinical research in diabetes.
< Page 1 | Page 3 >